Navigation Links
SHOW DAD YOU LOVE HIS FACE
Date:6/4/2009

For Father's Day, Forget The Usual With A Gift That Does Wonders For His Skin

Dermagenics Physician Formulated Anti-Wrinkle Moisturizer

PACIFIC PALISADES, Calif., June 4 /PRNewswire/ -- Forget ties and cologne for Father's Day. This year, give Dad something he secretly desires but may not buy for himself: An Anti-Wrinkle Moisturizer -- and only the best for the family hero. Dermagenics Physician-Formulated Anti-Wrinkle Moisturizer is an all-in-one cream formulated for the face, eyes, and neck that will enhance his natural good looks and promote healthier skin -- and it contains no perfumes, dyes, or other irritants. Men love it!

Since men don't typically wear makeup, Dermagenics gives them the advantage to having beautiful skin, naturally. Dermagenics' all-in-one Anti-Wrinkle Moisturizer is gentle enough for the under-eye area, yet powerful enough for the face and neck. A single jar of Dermagenics provides intensive care for the entire face, eliminating the need for multiple skin-care products. Designed for day and night use, Dermagenics contains powerful natural ingredients and the latest patented anti-aging discoveries. It comes in a shiny silver 1.7 oz. jar and contains no potentially harmful chemicals commonly found in other skin creams, such as alpha hydroxys or glycolic acid, formaldehyde, wax, or nylon.

Dermagenics' multi-task Anti-Wrinkle Moisturizer all-in-one jar, which replaces a separate face cream, eye cream, anti-aging serum, and neck cream, makes it one of the most affordable moisturizers, on sale at just $39.95 for Father's Day. Ladies can buy an additional jar for themselves.

Dermagenics can be purchased on the Internet at www.dermagenics.biz or by calling the toll free number, 1-877-754-6289.

Dermagenics is distributed by Universal Skin Technologies, LLC, headquartered at 15332 Antioch St., #446, Pacific Palisades, CA 90272. The telephone number is 1-877-754-6289.


'/>"/>
SOURCE Dermagenics
Copyright©2009 PR Newswire.
All rights reserved

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... Ariz. (PRWEB) , ... June 28, 2017 , ... ... proud to announce that its 50ml Liquid Stevia Sweet Drops™ have received the ... undergone the verification process from the Non-GMO Project, the only third-party verification for ...
(Date:6/28/2017)... ... June 28, 2017 , ... Eating disorders have the highest ... minutes, at least one person dies as a direct result from an eating disorder ... for qualified treatment providers. The iaedp Foundation meets this challenge by offering what has ...
(Date:6/28/2017)... ... June 28, 2017 , ... Canadian Zeolite ... that a two year study conducted by the University of Saskatchewan in partnership ... in remediating potash brine-impacted groundwater. As a part of the study, batch adsorption ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... of Mike Finnegan to the position of Executive Vice President, Sales and Marketing. ... healthcare technology, telehealth and medical device sales leadership. He has received industry recognition ...
(Date:6/27/2017)... BOSTON, MA (PRWEB) , ... June 27, 2017 , ... ... U.S. Senate bill to repeal and replace the 2010 Patient Protection and Affordable Care ... as compared with what would be expected under current law. , More than 20 ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... 2017 AirXpanders, Inc. (ASX: AXP) (AirXpanders or ... manufacture, sale and distribution of the AeroForm® Tissue Expander ... its commercial roll-out in the United States ... one hundred (100) medical institutions and health systems, located ... needle-free alternative for women who choose reconstructive surgery following ...
(Date:6/7/2017)... 7, 2017 Endo International plc (NASDAQ: ... the Hon. Joseph R. Goodwin , U.S. District ... West Virginia , entered a case management order ... System Products Liability Litigation (the "MDL") that includes a ... provide expert disclosures on specific causation within one hundred ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology: